Prostate Cancer–specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users
Background: Metformin has been linked to improved survival among diabetic prostate cancer (PCa) patients, while hyperinsulinemia and insulin usage has been related to worse prognosis. Objective: To evaluate the association of metformin and other antidiabetic drugs with PCa death and androgen depriva...
Enregistré dans:
Auteurs principaux: | Roni M. Joentausta, Antti Rannikko, Teemu J. Murtola |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f5dcd5eaf96f450ab6bca2a9e60b410e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The first 10 years’ experience in radical retropubic prostatectomy: Complications, lower urinary tract symptoms, and quality of life - a single-center experience
par: Dinić Ljubomir, et autres
Publié: (2021) -
Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?
par: Nicolas Giraud, et autres
Publié: (2021) -
Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study
par: Xianghong Zhou, et autres
Publié: (2021) -
18F-choline positron emission tomography/computed tomography guided laparoscopic salvage lymph node dissection in patients after radical prostatectomy
par: Markiian Kubis, et autres
Publié: (2020) -
Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S
par: Pan J, et autres
Publié: (2019)